'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer

Dr. Randolph Says Bioidentical Testosterone Can Promote Prostate Health

Jacksonville, Fla. (Vocus/PRWEB ) July 9, 2009 --

On June 30th, the Institute of Medicine released a list of 100 priorities it recommends for "comparative effectiveness" research. Among the 100 different questions posed, high on the list was this question regarding what should be regarded as the treatment-of-choice for prostate cancer: "What's best for early stage prostate cancer - various surgeries, different types of radiation, or so- called watchful waiting?"

C.W. Randolph, Jr. ,M.D., R.Ph, board certified physician and nationally-recognized expert in the field of hormone health is a proponent of a more preventative approach.

"There is a common misconception that lower testosterone levels mean a lower risk of prostate cancer. Men hardly ever develop prostate cancer when they are young and their testosterone levels are at a lifetime peak. On the contrary, as men age and their body's production of testosterone increasingly declines, they are at a much greater risk of developing this life-altering disease," says Randolph. "In my practice, I restore a man's optimum testosterone levels with bioidentical testosterone and almost always see an improvement in prostate health."

Randolph's medical opinion has been validated by such respected medical researchers as Abraham Morgentaler, M.D., Associate Clinical Professor of Urology at Harvard University Medical School. And recent articles published in the New England Journal of Medicine and the Journal of the National Cancer Institute substantiate how restoring healthy testosterone levels can help to protect the prostate.

Dr. Randolph contends: "More and more physicians are coming around to recognize that bioidentical testosterone therapy can benefit the prostate but it will probably take years for the traditional medical community at-large to alter their established, misguided beliefs. That is why in our latest book In the Mood Again we not only speak to how bioidentical testosterone can re-charge an aging man's sex life, we also share the medical evidence of its positive prostate health effects. Rather than sort through the options for prostate cancer treatment, I challenge more medical scientists and physicians to read our book and, also, examine the clinical evidence linking high testosterone with better long-term prostate health. Almost always, restoring optimum hormone levels is a huge step in preventative medicine and I can assure you that your male patients will thank you for it."